757024

    213326

    ACCPL

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    ACCRETION PHARMA LIMITED Share Price Today

    ACCRETION PHARMA LIMITED is currently trading at ₹165.5, down by ₹0.5 from the previous close. The stock touched an intraday high of ₹168.95 and a low of ₹165.50 during the latest trading session. Over the past one year, ACCRETION PHARMA LIMITED has delivered a return of 151.55%, while the stock has gained 11.88% in the last one month.

    ACCRETION PHARMA LIMITED performance

    Today’s low Today’s high
    ₹ 165.50 ₹ 168.95
    ₹ 165.65
    52 week low 52 week high
    ₹ 53.80 ₹ 171.15
    ₹ 165.65
    Open Price ₹ 168.95
    Prev. Close ₹ 166.00
    Volume (Shares) 38400.00
    Total traded value ₹ 63.60
    Upper Circuit ₹ 174.30
    Lower Circuit ₹ 157.70
    info

    Investment Returns

    Over 1 Month 11.88% Over 3 Months 99.93% Over 6 Months 143.42% Over 1 Year 151.55%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    ACCRETION PHARMA LIMITED fundamentals


    • Market cap (Cr) 184.10
    • P/E Ratio (TTM) 19.04
    • Beta 0.66
    • Book Value / share 49.21
    • Return on equity 65.35%
    • EPS (TTM) 8.70
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 0.00
    info icon alternate text
    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) [-]
    info icon alternate text

    ACCRETION PHARMA LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 89.63
    Operating Expense 76.74
    Net Profit 9.67
    Net Profit Margin (%) 10.78
    Earnings Per Share (EPS) 9.03
    EBITDA 15.14
    Effective Tax Rate (%) 26.14
    Particulars MAR 2025 (Values in Cr)
    Revenue 57.38
    Operating Expense 47.71
    Net Profit 6.79
    Net Profit Margin (%) 11.83
    Earnings Per Share (EPS) 8.48
    EBITDA 11.96
    Effective Tax Rate (%) 30.43
    Particulars MAR 2024 (Values in Cr)
    Revenue 13.35
    Operating Expense 11.41
    Net Profit 1.49
    Net Profit Margin (%) 11.16
    Earnings Per Share (EPS) 1.96
    EBITDA 2.62
    Effective Tax Rate (%) 25.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 29.38
    Operating Expense 29.40
    Net Profit 0.10
    Net Profit Margin (%) 0.34
    Earnings Per Share (EPS) 0.27
    EBITDA 2.14
    Effective Tax Rate (%) 21.42
    Particulars MAR 2022 (Values in Cr)
    Revenue 22.29
    Operating Expense 22.48
    Net Profit 0.08
    Net Profit Margin (%) 0.35
    Earnings Per Share (EPS) 0.25
    EBITDA 1.93
    Effective Tax Rate (%) 30.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 18.71
    ROE % 65.35
    ROCE % 46.32
    Total Debt to Total Equity 1.33
    EBITDA Margin 20.88
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 13.73
    ROE % 27.14
    ROCE % 12.60
    Total Debt to Total Equity 2.46
    EBITDA Margin 19.63
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.05
    Total Assets 39.87
    Total Liabilities 39.87
    Total Equity 15.28
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 17.03
    Return on Capital (%) 23.12
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.09
    Total Assets 27.43
    Total Liabilities 27.43
    Total Equity 5.49
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 5.44
    Return on Capital (%) 7.87
    Particulars MAR 2025 (Values in Cr)
    Net Income 9.76
    Cash from Operations 7.60
    Cash from Investing -1.61
    Cash from Financing -4.18
    Net change in Cash -0.04
    Free Cash Flow 9.21
    Particulars MAR 2024 (Values in Cr)
    Net Income 1.99
    Cash from Operations -12.29
    Cash from Investing -5.47
    Cash from Financing 17.07
    Net change in Cash 0.09
    Free Cash Flow -6.81
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.96 12.85 1.49 237.26 23.12 38.85
    BLISS GVS PHARMA LTD. 482.50 38.79 4.28 5117.21 118.35 552.90
    CIPLA LTD 1418.40 30.10 3.32 114584.78 1165.55 1672.20
    FERMENTA BIOTECH LTD. 431.50 19.03 3.12 1269.95 256.40 480.00
    GLAXOSMITHKLINE PHARMACEUTICAL 2455.05 43.22 18.34 41590.03 2088.00 3217.10
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.96 21.65 3.98 237.26 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 537.90 24.11 4.20 1555.10 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8025.95 104.82 22.98 20064.88 7630.00 9850.00
    BLISS GVS PHARMA LTD. 482.50 52.16 4.42 5117.21 118.35 552.90

    ACCRETION PHARMA LIMITED shareholding pattern

    Holding
    26.48%
    73.51%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    ACCRETION PHARMA LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    165.65 -0.21 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 162.30
    • 26 Days 152.20
    • 10 Days 160.00
    • 50 Days 139.10
    • 12 Days 159.20
    • 100 Days 119.50
    • 20 Days 155.40
    • 200 Days 99.90
    166.00 PIVOT
    First Support 166.00 First Resistance 166.00 Second Support 166.00 Second Resistance 166.00 Third Support 166.00 Third Resistance 166.00
    RSI 63.64 ADX 35.39 MACD 6.92 Williams % R -31.25 Commodity Channel Index (CCI) 131.07
    Date 2026-07-17 Week 12400.00 Same Day 38400.00 Month 23073.00
    1 Year 0.66 3 Year 0.60
    Over 1 Month
    11.88% down
    Over 1 Year
    151.55% down
    Over 3 Months
    99.93% down
    Over 3 Years
    0.00% down
    Over 6 Months
    143.42% down
    Over 5 Years
    0.00% down

    ACCRETION PHARMA LIMITED Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Accretion Pharmaceuticals Ltd?

    Answer Field

    Accretion Pharmaceuticals Ltd share price is for NSE ₹ 165.50 & for BSE ₹ 0.00 as on Jul 17 2026 03:26 PM.

    What is the Market Cap of Accretion Pharmaceuticals Ltd Share?

    Answer Field

    The market cap of Accretion Pharmaceuticals Ltd for NSE ₹ 184.10 & for BSE ₹ 0.00 as on Jul 17 2026 03:26 PM.

    What is the 52 Week High and Low of Accretion Pharmaceuticals Ltd?

    Answer Field

    The 52 Week High and Low of Accretion Pharmaceuticals Ltd for NSE is ₹ 171.15 and ₹ 53.80 and for BSE is ₹ 0.00 and ₹ 0.00.

    What is 1 year return for Accretion Pharmaceuticals Ltd?

    Answer Field

    The 1 year returns on the stock has been 151.55%.

    What is the P/E Ratio of Accretion Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 17 2026 03:26 PM the price-to-earnings (PE) ratio for Accretion Pharmaceuticals Ltd share is 19.04.

    What is the PB ratio of Accretion Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 17 2026 03:26 PM, the price-to-book (PB) ratio for Accretion Pharmaceuticals Ltd share is 49.21.

    How to Buy Accretion Pharmaceuticals Ltd Share?

    Answer Field

    You can trade in Accretion Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Accretion Pharmaceuticals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Accretion Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Accretion Pharmaceuticals Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |